Market Overview

Goldman Says FDA Response to Energy Drink Safety Review 'Encouraging' for Monster

Related MNST
Believe It Or Not, Morgan Stanley Says Buying Beer Is A Smart Investment
Benzinga's Top Downgrades
Making Money With Charles Payne: 12/8/14 (Fox Business)

Commenting on the action in Monster Beverage this afternoon, Goldman Sachs analyst Judy Hong called the FDA's response to the energy drink safety issue "generally benign." Hong believes this should be encouraging for Monster. The analyst believes the most likely outcome related to Durbin's energy drink review will be strong labeling, something which is unlikely to have a material impact on Monster.

Latest Ratings for MNST

DateFirmActionFromTo
Dec 2014CLSAUpgradesOutperformBuy
Dec 2014RBC CapitalDowngradesTop PickOutperform
Nov 2014Longbow ResearchAssumesNeutral

View More Analyst Ratings for MNST
View the Latest Analyst Ratings

Posted-In: Analyst Color Analyst Ratings Movers

 

Related Articles (MNST)

Around the Web, We're Loving...

Get Benzinga's Newsletters